OIC Drugs Market Revolution: Liberating Lives from Constipation | CAGR of 4.9%
The global opioid induced constipation (OIC) drugs market is projected to reach $1785.01 million by 2031, growing at a CAGR of 4.9% from 2022 to 2031.
PORTLAND, OREGON, UNITED STATES, October 5, 2023 /EINPresswire.com/ -- Opioid-induced constipation (OIC) is a common side effect experienced by patients who take opioid medications for pain management. Opioids bind to receptors in the gastrointestinal tract, slowing down bowel movements and leading to constipation. To address this issue, specific drugs have been developed to target OIC and provide relief to patients. The global opioid induced constipation (OIC) drugs market was valued at $1105.71 million in 2021, and is projected to reach $1785.01 million by 2031, growing at a CAGR of 4.9% from 2022 to 2031.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐎𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/request-sample/13745
One class of drugs used to manage OIC is known as peripherally acting mu-opioid receptor antagonists (PAMORAs). These medications, such as naloxegol and methylnaltrexone, work by selectively blocking opioid receptors in the gut without affecting pain relief in other areas. By reversing the constipating effects of opioids, PAMORAs help restore normal bowel function and alleviate OIC symptoms.
Major market players covered in the report, such as -
AstraZeneca plc,
cosmo pharmaceuticals,
Dr. Reddy’s Laboratories Ltd.,
Mallinckrodt plc,
Novartis AG,
Teva Pharmaceutical Industries Ltd.,
Shionogi & Co., Ltd.,
Bausch Health Companies Inc.,
Merck & Co., Inc.,
Takeda Pharmaceutical Company Limited
𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟐𝟎 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @
https://www.alliedmarketresearch.com/opioid-induced-constipation-oic-drugs-market/purchase-options
Key Benefits for Stakeholders -
• The report provides quantitative analysis of market segments, current trends, strategies and potential of Opioid Induced Constipation (OIC) Drugs Market research to identify potential Opioid Induced Constipation (OIC) Drugs Market opportunities in genetics.
• In-depth analysis of this sector helps identify current market opportunities.
• Market analysis and information related to key drivers, restraints and opportunities are provided.
• Porter's Five Forces Analysis identifies the capabilities of buyers and suppliers to enable stakeholders to make profitable business decisions and strengthen the network of buyers.
• The largest countries in each region are listed according to their contribution to the global market.
• Focusing on market players makes benchmarking easier and provides a clear understanding of the current market situation.
• The report includes regional and global Opioid Induced Constipation (OIC) Drugs Market analysis, key players, market segments, application areas and Market growth strategies.
Another approach to managing OIC involves the use of stool softeners, laxatives, and bowel stimulants. These drugs, such as polyethylene glycol (PEG) and stimulant laxatives like bisacodyl, promote bowel movement by increasing water content in the intestines or stimulating the muscles in the gastrointestinal tract. They help soften the stool and relieve constipation caused by opioid use.
It is worth noting that the choice of OIC drug depends on factors such as the severity of constipation, individual patient characteristics, and the specific opioid being used. Healthcare providers work closely with patients to determine the most suitable treatment option and adjust medication regimens accordingly. Managing OIC effectively is crucial to ensure optimal pain management and improve the overall quality of life for patients taking opioids for chronic pain conditions.
𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐄𝐧𝐪𝐮𝐢𝐫𝐲 -
https://www.alliedmarketresearch.com/purchase-enquiry/13745
Frequently Asked Questions?
Q1. What are the upcoming trends of Opioid Induced Constipation (OIC) Drugs Market in the world?
Q2. What is the leading application of Opioid Induced Constipation (OIC) Drugs Market?
Q3. Which is the largest regional market for Opioid Induced Constipation (OIC) Drugs?
Q4. What is the estimated industry size of Opioid Induced Constipation (OIC) Drugs?
Q5. Which are the top companies to hold the market share in Opioid Induced Constipation (OIC) Drugs?
Q6. What would be forecast period in the market report?
About Us -
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
